GlassScriptPhysician profile
Varun Tandon
NPI 1902251903
$11,580.65
in general payments reported to CMS, 2019-2025
27 companies · $4,905 in 2025
The $4,905 reported for 2025 was more than what 83% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2021: $137 · 2022: $832 · 2023: $2,776 · 2024: $2,682 · 2025: $4,905.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,141 · Travel and Lodging: $2,849 · Education: $374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,140.60 |
| Travel and Lodging | $2,848.77 |
| Education | $373.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,208.50 | 2021-2025 | General - Balloon Catheters, Avvigo Guidance System, Rotapro |
| Penumbra, INC. | $2,058.20 | 2025 | Indigo System |
| Medtronic, INC. | $1,772.86 | 2021-2025 | Venaseal, Resolute Onyx, Symplicity G3 |
| Abiomed | $1,141.48 | 2024-2025 | Impella |
| Shockwave Medical, INC | $1,093.14 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Aop Health US, LLC | $942.43 | 2025 | Rapiblyk |
| Abbott Laboratories | $456.78 | 2022-2025 | Ensite, Dragonfly Opstar, Cardiomems |
| Atricure, INC. | $274.61 | 2022-2024 | |
| Amgen INC. | $258.07 | 2021-2025 | Repatha, Repatha |
| Mylan Specialty L.P. | $247.91 | 2019 | |
| Edwards Lifesciences Corporation | $188.97 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $161.88 | 2021-2023 | Lifevest |
| Novartis Pharmaceuticals Corporation | $156.50 | 2024-2025 | |
| Kestra Medical Technology Services, INC. | $114.24 | 2025 | Assure Wcd |
| Cleerly, INC. | $96.76 | 2025 | Cleerly Ischemia, Cleerly Labs |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $91.54 | 2025 | Optimizer |
| E.R. Squibb & Sons, L.L.C. | $86.01 | 2024-2025 | Eliquis, Camzyos |
| Angiodynamics, INC. | $43.05 | 2025 | Auryon Laser System 100-120 Vac |
| Livanova USA, INC. | $38.50 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $28.06 | 2024 | Arcalyst |
| Terumo Medical Corporation | $23.87 | 2022 | |
| B. Braun Interventional Systems INC. | $18.12 | 2025 | Ono Retrieval Device |
| Stryker Corporation | $16.96 | 2025 | Flowtriever |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.66 | 2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $16.40 | 2025 | |
| Merck Sharp & Dohme LLC | $15.98 | 2025 | Verquvo |
| Pfizer INC. | $13.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Varun Tandon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.